Ann: Proposed issue of securities - SNT, page-21

I think there is probably quite a large pocket of retail investors who love biotech and lap up any media produced in the sector and of particular interest is hearing from a specialist biotech investor which is relatively rare in Aus - for whatever reason, presumably to drum up interest in his new fund, Hashan has been on a fair media go around in the last few months.

But I agree with you - whilst the Neuren trade is impressive, he wasn't the only one, and it doesn't mean everything he is involved in will turn to gold.